Suchergebnisse - "Gaudinski, Martin R"

PubPharm (32)

1

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization

enthalten in: bioRxiv.org | 2024

von Doria-Rose, N. | Shen, X. | Schmidt, S. | +33

2

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS

enthalten in: JCI insight | 2024

von Awan, S. | Pegu, A. | Strom, L. | +34

3

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

enthalten in: NPJ vaccines | 2024

von Happe, M. | Hofstetter, A. | Wang, J. | +95

4

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults : a phase 1, open-label, dose-escalation clinical trial

enthalten in: The Lancet. Infectious diseases | 2023

von Mwesigwa, B. | Houser, K. | Hofstetter, A. | +73

ErratumIn: Lancet Infect Dis. 2023 Oct;23(10):e400. - PMID 37652067

5

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C) : a phase 1, adaptive trial

enthalten in: The Lancet. Infectious diseases | 2023

von Lyke, K. | Berry, A. | Mason, K. | +98

CommentIn: Lancet Infect Dis. 2023 May;23(5):514-516. - PMID 36708739

6

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

enthalten in: Science translational medicine | 2023

von Widge, A. | Hofstetter, A. | Houser, K. | +123

7

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA : a first-in-human, phase 1, open-label, dose-escalation trial

enthalten in: Lancet (London, England) | 2023

von Hamer, M. | Houser, K. | Hofstetter, A. | +53

CommentIn: Lancet. 2023 Jan 28;401(10373):251-253. - PMID 36709065

8

Clonal hematopoiesis is not significantly associated with COVID-19 disease severity

enthalten in: Blood | 2022

von Zhou, Y. | Shalhoub, R. | Rogers, S. | +41

9

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

enthalten in: The New England journal of medicine | 2022

von Wu, R. | Idris, A. | Berkowitz, N. | +127

CommentIn: N Engl J Med. 2022 Aug 4;387(5):460-461. - PMID 35921456

10

Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV : a phase 1, dose-escalation trial

enthalten in: Nature medicine | 2022

von Casazza, J. | Cale, E. | Narpala, S. | +85